Zobrazeno 1 - 10
of 165
pro vyhledávání: '"R. Mione"'
Publikováno v:
European Heart Journal Supplements. 25:D189-D189
Background–Aim A man of 81 years, with previous coronary artery disease, unrecognized myocardial infarction, carrier of implanted pacemaker, presented to the cardiology department for a scheduled hospitalization to treat shortness of breath and sym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::047f045f451f310030a7f925487a1c90
https://doi.org/10.1093/eurheartjsupp/suad111.443
https://doi.org/10.1093/eurheartjsupp/suad111.443
Autor:
Diana Lüftner, Kurt Possinger, R Mione, John F.R. Robertson, R Molina, Massimo Gion, A E Leon
Publikováno v:
European Journal of Cancer. 37:355-363
Recently, a fully automated method has become commercially available to measure the MUC-1-associated antigen CA27.29. The present investigation was performed in order to compare CA27.29 and CA15.3 in a wide series of patients affected with breast can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11e59e4d0fa17aabcfa552d6e1979752
https://doi.org/10.1016/s0959-8049(00)00396-8
https://doi.org/10.1016/s0959-8049(00)00396-8
Publikováno v:
Tumor Biology. 19:269-274
Tumor markers are currently monitored on a routine basis. However, their impact on the course of a disease is still under debate. This relative uncertainty leads to a subjective approach to their use. In order to evaluate the range in the pattern of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5acc31e28e6296764e7189afe81c33c5
https://doi.org/10.1159/000030017
https://doi.org/10.1159/000030017
Autor:
Giuseppe Aimo, Ines Abbate, M. Correale, R Mione, Emilio Bombardieri, M Barichello, Paola Barioli, Massimo Gion, Carlo Terrone, Antonio Pagliarulo, S. Massaron, Domenico Marzano, Alberto Cianetti, Ettore Seregni
Publikováno v:
Scopus-Elsevier
Aims and BackgroundThe free/total (F/T) prostate-specific antigen (PSA) ratio is probably the most promising tool proposed to increase the specificity of PSA in the diagnosis of prostate cancer. The aim of the present study was to evaluate the clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::725b30e6b3be48c111b1232bd61dab68
https://doi.org/10.1177/030089169608200606
https://doi.org/10.1177/030089169608200606
Autor:
F De Biasi, E Gianneo, S. Praturlon, Paola Barioli, M Barichello, G Cocco, Ruggero Dittadi, R Antinozzi, G Cazzolato, G Capitanio, Massimo Gion, R Mione
Publikováno v:
Clinical Chemistry. 42:1634-1638
The determination of tumor markers in urine samples has been proposed as an effective diagnostic tool in bladder cancer. The aim of the present investigation was to validate in urine samples the assay of the CYFRA21.1 cytokeratin-related marker, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb2d281265813532180ecc1d31933697
https://doi.org/10.1093/clinchem/42.10.1634
https://doi.org/10.1093/clinchem/42.10.1634
Publikováno v:
The International Journal of Biological Markers. 10:229-235
The ultrasensitive PSA assay has been recently acknowledged as a useful tool for the monitoring of patients prostatectomized for prostatic cancer. We have evaluated a commercially available ultrasensitive PSA assay (Immulite Third Generation PSA - DP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98417ce70514ebd1897fd96ecc6717bd
https://doi.org/10.1177/172460089501000408
https://doi.org/10.1177/172460089501000408
Autor:
Massimo Gion, Ruggero Dittadi, M. Romanelli, G. Capitanio, U. Friede, S. Dante, A. Visonà, R Mione, R. Barbazza, L. Pappagallo
Publikováno v:
European Journal of Cancer. 31:671-677
The relationship between cathepsin D and other pathological or biological prognostic parameters has not yet been defined through systematic studies in breast cancer. The aim of the present investigation was to define the relationship between cathepsi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73b294756a64512f4996406036165740
https://doi.org/10.1016/0959-8049(94)00532-a
https://doi.org/10.1016/0959-8049(94)00532-a
Autor:
G Cappelli, Massimo Gion, R. Mione, R Biasioli, G Vignati, A Fortunato, S Saracchini, M. Gulisano, P. Barioli
Publikováno v:
Annals of Oncology. 6:S31-S35
Summary Background Although tumor markers are frequently used in the follow-up of patients with breast cancer, two points are still being debated: 1) their cost/effectiveness has been neither demonstrated nor disproved; 2) the reliability of the curr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d43f96fd085272633d6de66708cbe1f
https://doi.org/10.1093/annonc/6.suppl_2.s31
https://doi.org/10.1093/annonc/6.suppl_2.s31
Autor:
Adriano Piffanelli, Manuela Balzi, M. Fontanesi, Massimo Gion, M. Correale, Giovannini G, G. Saccani Jotti, R Mione, Aldo Becciolini
Publikováno v:
Scopus-Elsevier
The serological tumor marker tissue polypeptide antigen (TPA) and the more recently identified tissue-specific polypeptide antigen (TPS) have been reported to be indicators of the proliferation rate of the tumor. In the present investigation we compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f9d41582776c96a9e1bad0c0a5df08d
https://doi.org/10.1177/172460089400900208
https://doi.org/10.1177/172460089400900208
Publikováno v:
British Journal of Cancer
We carried out a comparison of three commonly used mucin markers, CA549, CA15.3 and MCA. Serum samples from 184 healthy women and 237 patients with primary breast cancer were evaluated. The markers were measured using commercially available immunomet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93d41a23e213e3db4f13c49502b100cc
http://europepmc.org/articles/PMC1968804
http://europepmc.org/articles/PMC1968804